Display Settings:

Format

Send to:

Choose Destination
    Biotechnol J. 2008 May;3(5):624-30.

    Assessment of cell engineering strategies for improved therapeutic protein production in CHO cells.

    Source

    Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejon, Korea.

    Abstract

    Recombinant glycoprotein therapeutics have proven to be invaluable pharmaceuticals for the treatment of various diseases. Chinese hamster ovary (CHO) cells are widely used in industry for the production of these proteins. Several strategies for engineering CHO cells for improved protein production have been tried with considerable results. The focus has mainly been to increase the specific productivity and to extend the culture longevity by preventing programmed cell death. These CHO cell engineering strategies, particularly those developed in Korea, are reviewed here.

    PMID:
    18293320
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for John Wiley & Sons, Inc.

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk